.png)
Promega, Wisconsin, United States
Matthew Robers is a Distinguished Senior Research Scientist and Group Leader at Promega Corporation. Matthew received his initial post-graduate training at University of Wisconsin-Madison, studying iron-sulfur cluster enzymes in bacteria. Matthew then focused on technology development and cellular pathway analysis at Life Technologies (Invitrogen). Since joining Promega, Matthew has built a team focused on the development of new technologies to assess intracellular target engagement, residence time, and drug polypharmacology. Through industry/academic collaborations, Matthew has generated over 10 patents and over 50 peer-reviewed publications emphasizing biophysical techniques to enable live cell target occupancy. Matthew is currently completing his PhD dissertation at the Structural Genomics Consortium, under the mentorship of Stefan Knapp.
Disclosure information not submitted.
Screen Design and Assay Technology
Monday, February 5, 2024
1:00 PM – 2:00 PM EST